Updates with Thorne's response in paragraph 8

June 26 (Reuters) - Unilever ULVR.L is exploring a bid for U.S. supplements maker Thorne, the Financial Times reported on Friday, as the consumer goods giant accelerates its shift towards beauty and wellbeing brands under CEO Fernando Fernandez.

Since taking over in March 2025, Fernandez has sought to reshape Unilever's portfolio.

In March, the Dove soap and Axe deodorant maker said it would combine its food business with U.S. spice maker McCormick MKC.N. Soon after, Unilever said it would buy U.S.-based nutritional supplements brand Grüns ‌for an undisclosed amount, expanding its wellbeing lineup.

The FT said Unilever was among several bidders for South Carolina-based Thorne, which is valued at up to $4 billion and sells dietary supplements, including magnesium and omega-3, primarily in the U.S.

Thorne, which was acquired by LVMH-backed LVMH.PA private equity firm L Catterton for $680 million in 2023, has attracted strategic interest, including a bid from consumer healthcare group Haleon HLN.L, two people familiar with the matter had told Reuters.

A Haleon spokesperson said the company did not comment on rumour or speculation.

Unilever and L Catterton declined to comment on the FT report, while the latter also did not immediately respond to a request for comment on the reported Haleon bid.

Thorne declined to comment on the reported bids from Unilever and Haleon.

Unilever bought hair supplements brand Nutrafol in 2022, SmartyPants Vitamins in 2020 and gummy brand Olly Nutrition in 2019, while Haleon has been focusing on faster-growing health categories, including oral care and consumer wellness.